Altimmune, Inc.
ALT
$5.61
-$0.36-6.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.18M | -22.85M | -24.64M | -24.39M | -31.64M |
| Total Depreciation and Amortization | 33.00K | 37.00K | 61.00K | 107.00K | 114.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.42M | 2.09M | 3.32M | 2.68M | 14.17M |
| Change in Net Operating Assets | 2.46M | -6.40M | 3.16M | 5.26M | 821.00K |
| Cash from Operations | -18.27M | -27.12M | -18.11M | -16.36M | -16.53M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.63M | 1.20M | -3.70M | -39.52M | -7.96M |
| Cash from Investing | 13.63M | 1.20M | -3.70M | -39.52M | -7.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.09M | 270.00K | 198.00K | 339.00K | 72.79M |
| Repurchase of Common Stock | -2.00K | -4.00K | -244.00K | -600.00K | -37.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 10.09M | 266.00K | -46.00K | -261.00K | 72.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.45M | -25.65M | -21.85M | -56.14M | 48.26M |
